CXCR4-Binding Positron Emission Tomography Tracers Link Monocyte Recruitment and Endothelial Injury in Murine Atherosclerosis.

Arterioscler Thromb Vasc Biol 2020 Dec 17:ATVBAHA120315053. Epub 2020 Dec 17.

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis. (O.B., L.-H.H., A.E., G.J.R.).

Objective: vMIP-II (viral macrophage inflammatory protein 2)/vCCL2 binds to multiple chemokine receptors, and vMIP-II-based positron emission tomography tracer (Cu-DOTA-vMIP-II: vMIP-II tracer) accumulates at atherosclerotic lesions in mice. Given that it would be expected to react with multiple chemokine receptors on monocytes and macrophages, we wondered if its accumulation in atherosclerosis lesion-bearing mice might correlate with overall macrophage burden or, alternatively, the pace of monocyte recruitment. Approach and Results: We employed a mouse model of atherosclerosis regression involving adenoassociated virus 8 vector encoding murine Apoe (AAV-mApoE) treatment of mice where the pace of monocyte recruitment slows before macrophage burden subsequently declines. Accumulation of Cu-DOTA-vMIP-II at plaque sites was strong but declined with AAV--induced decline in monocyte recruitment, before macrophage burden reduced. Monocyte depletion indicated that monocytes and macrophages themselves were not the only target of the Cu-DOTA-vMIP-II tracer. Using fluorescence-tagged vMIP-II tracer, competitive receptor blocking with CXCR4 antagonists, endothelial-specific Cre-mediated deletion of CXCR4, CXCR4-specific tracer Cu-DOTA-FC131, and CXCR4 staining during disease progression and regression, we show endothelial cell expression of CXCR4 is a key target of Cu-DOTA-vMIP-II imaging. Expression of CXCR4 was low in nonplaque areas but strongly detected on endothelium of progressing plaques, especially on proliferating endothelium, where vascular permeability was increased and monocyte recruitment was the strongest.

Conclusions: Endothelial injury status of plaques is marked by CXCR4 expression and that this injury correlates with the tendency of such plaques to recruit monocytes. Furthermore, our findings suggest positron emission tomography tracers that mark CXCR4 can be used translationally to monitor the state of plaque injury and monocyte recruitment.

Download full-text PDF

Source Listing
December 2020

Publication Analysis

Top Keywords

monocyte recruitment
emission tomography
positron emission
macrophage burden
multiple chemokine
target cu-dota-vmip-ii
monocytes macrophages
chemokine receptors
endothelial injury
pace monocyte
tomography tracers
vmip-ii tracer
expression cxcr4
treatment mice
apoe aav-mapoe
cxcr4 low

Similar Publications

PET imaging of chemokine receptors in vascular injury-accelerated atherosclerosis.

J Nucl Med 2013 Jul 8;54(7):1135-41. Epub 2013 May 8.

Department of Radiology, Washington University, St. Louis, Missouri 63110, USA.

Unlabelled: Atherosclerosis is the pathophysiologic process behind lethal cardiovascular diseases. It is a chronic inflammatory progression. Chemokines can strongly affect the initiation and progression of atherosclerosis by controlling the trafficking of inflammatory cells in vivo through interaction with their receptors. Read More

View Article and Full-Text PDF
July 2013

PET/CT Imaging of Chemokine Receptors in Inflammatory Atherosclerosis Using Targeted Nanoparticles.

J Nucl Med 2016 07 21;57(7):1124-9. Epub 2016 Jan 21.

Department of Radiology, Washington University, St. Louis, Missouri

Unlabelled: Atherosclerosis is inherently an inflammatory process that is strongly affected by the chemokine-chemokine receptor axes regulating the trafficking of inflammatory cells at all stages of the disease. Of the chemokine receptor family, some specifically upregulated on macrophages play a critical role in plaque development and may have the potential to track plaque progression. However, the diagnostic potential of these chemokine receptors has not been fully realized. Read More

View Article and Full-Text PDF
July 2016

Molecular Imaging Visualizes Recruitment of Inflammatory Monocytes and Macrophages to the Injured Heart.

Circ Res 2019 03;124(6):881-890

Department of Medicine (B.K., G.F., G.B., S.L.B., K.J.L.), Washington University School of Medicine, St. Louis, MO.

Rationale: Paradigm shifting studies have revealed that the heart contains functionally diverse populations of macrophages derived from distinct embryonic and adult hematopoietic progenitors. Under steady-state conditions, the heart is largely populated by CCR2- (C-C chemokine receptor type 2) macrophages of embryonic descent. After tissue injury, a dramatic shift in macrophage composition occurs whereby CCR2+ monocytes are recruited to the heart and differentiate into inflammatory CCR2+ macrophages that contribute to heart failure progression. Read More

View Article and Full-Text PDF
March 2019

A novel peptide antagonist of CXCR4 derived from the N-terminus of viral chemokine vMIP-II.

Biochemistry 2000 Apr;39(13):3782-7

Kimmel Cancer Institute, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

The viral macrophage inflammatory protein-II (vMIP-II) encoded by Kaposi's sarcoma-associated herpesvirus is unique among all known chemokines in that vMIP-II shows a broad-spectrum interaction with both CC and CXC chemokine receptors including CCR5 and CXCR4, two principal coreceptors for the cell entry of human immunodeficiency virus type 1 (HIV-1). To elucidate the mechanism of the promiscuous receptor interaction of vMIP-II, synthetic peptides derived from the N-terminus of vMIP-II were studied. In contrast to the full-length protein that recognizes both CXCR4 and CCR5, a peptide corresponding to residues 1-21 of vMIP-II (LGASWHRPDKCCLGYQKRPLP) was shown to strongly bind CXCR4, but not CCR5. Read More

View Article and Full-Text PDF
April 2000